Our new Lancet correspondence urges prioritizing pregnant & breastfeeding women in HIV prevention using the “Two for Two” approach: just 2 LEN injections over 6 months to protect both mom & baby. https://t.co/Ckj8rsqrpW
New review: long-acting HIV drugs are safe for pregnant/breastfeeding women, with more trials including them. Injectable PrEP is entering maternal health. Policy and cost challenges remain.
Read: https://t.co/US8zFRLBZw
#HIV#MaternalHealth#LongActingART
On Monday, Dr. Friday Saidi moderated one of the sessions at the 2025 Conference for Retroviruses and Opportunistic Infections in San Francisco! 🌟
The discussion included:
▶️ Maternal Tenofovir for preventing infant Hepatitis B
▶️Home visit strategies to promote family health and couple HIV testing
▶️The pharmacokinetics, safety, and efficacy of Lenacapavir for PrEP in adolescents and adults (Purpose 1 trial)
Congrats, Dr. Saidi, on a successful, well-attended discussion! 💬👏
@DrFridaySaidi | @unc_cwhr | #HIVresearch #obgyn
I am honored to have moderated a session on maternal and child health research at the ongoing #CROI2025 . The session was well-attended, featuring great presentations and engaging discussions. I am grateful for the opportunity to facilitate this important conversation!
Today we remember Professor James Gita Hakim on the 4th anniversary of his passing. He was a wonderful mentor and an inspiration to many people in the medical fraternity . May he rest in peace. 🙏🙏
Sharing our latest publication: a systematic review and narrative synthesis on the predictors of maternal HIV acquisition in sub-Saharan Africa.
https://t.co/UfNBCIUTFZ
“Oral PrEP maybe be altering the vaginal microbiota of pregnant women and predisposing them to the risk of preterm birth. A larger study is needed to confirm the findings.” says @DrFridaySaidi from the UNC Project - Malawi at #HIVR4P2024
I am honored to have received the Honorary Lynne Mofenson Award for the Outstanding presentation at the International HIV and Pediatrics Workshop. This award includes a full travel scholarship that will allow me to attend the 2025 workshop in Kigali, Rwanda. #HIVPED
Excited to be speaking at the 16th International Workshop on Pediatrics & HIV from 19-20 July 2024 in Munich, Germany!
Join the Discussion on What is New on Cabotegravir (CAB-LA) in Pregnancy: Progress on Implementation and Surveillance of Pregnancy Outcomes #HIVPED
This Thursday and Friday, we held a protocol training session for the O-PrEP study, a crucial initiative aimed at optimizing PrEP regimens for pregnant women in sub-Saharan Africa.
Her project will be an extension to the Pregnancy Infant and Maternal Health Outcome (PRIMO), with @DrFridaySaidi as her primary mentor. She will explore “facilitators and barriers to long-acting injectable PrEP use among pregnant and breastfeeding women”.
It’s a wrap for the inaugural African workshop on @HIV_and_Women. So many brilliant presentations, beautiful smiles, passionate people & candid testimonials. >400 delegates from 19 countries. Much food for thought. To be continued in Feb 2025, hope to see u there #HIVWOMENAFRICA
Happenning now! The Pregnancy, Breastfeeding and Contraception Session, exploring the Modern Contraceptive Options for Women on ART, and Does U=U Apply for Breastfeeding?
#HIVWOMENAFRICA
Session 2 is underway focusing on HIV prevention; New Prevention Regimens and How they Affect HIV care, updates on PrEP and Breastfeeding Practices Among Women Living with HIV.
#HIVWOMENAFRICA
Less than a week until #HIVWOMENAFRICA commences.
Don't miss this hybrid workshop dedicated to enhancing the quality of life for women living with #HIV and reducing viral transmissions in Africa 👉https://t.co/dOp1cBbtZw